See below for a list of our latest prescribing data reports and evidence reviews. If you’re looking for something in particular, please use the search function or get in touch at

For a summary of work in progress, see our forthcoming publications and work plan.

New and recent publications
Budesonide orodispersible tablets for maintenance of remission in eosinophilic oesophagitis
Electronic repeat dispensing: Understanding the prescribing population & initial barriers to uptake
Monthly Horizon Scanning Report – June 2022
Prescribing Update Newsletter – May 2022
Formulary assessment – estradiol/progesterone (Bijuve) for HRT
Formulary assessment – tirbanibulin (Klisyri)
Estradiol / progesterone (Bijuve®) for hormone replacement therapy in postmenopausal women
Monthly Horizon Scanning Report – May 2022
Formulary assessment – estradiol spray (Lenzetto)
Formulary assessment – testosterone 2% gel (Tostran) in post-menopausal women
Monthly Formulary Amendments – April 2022
Formulary assessment – Dacepton (apomorphine)
Comparison of DOACs for Atrial Fibrillation
Monthly Horizon Scanning Report – April 2022
Prescribing Update Newsletter – March 2022
Formulary assessment – levomepromazine 6mg tablets
Formulary assessment – indapamide 1.5mg modified release
Monthly Formulary Amendments – March 2022
Monthly Horizon Scanning Report – March 2022
Insulin aspart Sanofi (Trurapi): Biosimilar Insulin Aspart
Monthly Formulary Amendments – February 2022
Annual Horizon Scanning Report – 2022-2023
Monthly Horizon Scanning Report – February 2022
Prescribing Update Newsletter – January 2022
Monthly Formulary Amendments – January 2022
Monthly Horizon Scanning Report – January 2022
Estradiol spray for the treatment of menopausal symptoms
Monthly Formulary Amendments – December 2021
Monthly Horizon Scanning Report – December 2021
Monthly Formulary Amendments – November 2021
Monthly Horizon Scanning Report – November 2021
Prescribing Update Newsletter – November 2021
Monthly Horizon Scanning Report – October 2021
Prescribing Update Newsletter – September 2021
North of England Integrated Care Systems; Overprescribing
Reducing the carbon impact of inhalers across the North of England
Antimicrobial prescribing across the North of England
Monthly Horizon Scanning Report – September 2021
Monthly Horizon Scanning Report – August 2021
Omalizumab and dupilumab for chronic rhinosinusitis with nasal polyps
Atrial Fibrillation [NICE NG196]: Financial and commissioning impact
Prescribing Update Newsletter – July 2021
Monthly Horizon Scanning Report – July 2021